Abbott's New Coronary Imaging Platform Powered By Artificial Intelligence Launches in Europe

#artificialintelligence 

ABBOTT PARK, Ill., April 26, 2021 -- Abbott today announced that its new imaging platform powered by Ultreon 1.0 Software, is now CE Marked in Europe. This first-of-its-kind imaging software merges optical coherence tomography (OCT) – an imaging tool that provides physicians a comprehensive view inside an artery or blood vessel – with the power of artificial intelligence (AI) for enhanced visualization. The new Ultreon Software can automatically detect the severity of calcium-based blockages and measure vessel diameter to enhance the precision of physicians' decision-making during coronary stenting procedures. Unlike traditional imaging methods such as conventional angiography, Abbott's OCT technology uses near-infrared light to provide high-definition, precise imaging from within a blood vessel. OCT imaging also helps improve physicians' assessment of blockages in those vessels and optimize decisions related to stent selection, placement and deployment.

Duplicate Docs Excel Report

Title
None found

Similar Docs  Excel Report  more

TitleSimilaritySource
None found